{"type": "FeatureCollection", "features": [{"id": "10.1007/s40265-021-01505-1", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:15:22Z", "type": "Journal Article", "created": "2021-04-30", "title": "Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review", "description": "Soil-transmitted helminths (Ascaris lumbricoides, hookworm and Trichuris trichiura) infect about one-fifth of the world's population. The currently available drugs are all highly efficacious against A. lumbricoides. However, they are only moderately efficacious against hookworm and poorly efficacious against T. trichiura. Oxantel, a tetrahydropyrimidine derivative discovered in the 1970s, has recently been brought back to our attention given its high efficacy against T. trichiura infections (estimated 76% cure rate and 85% egg reduction rate at a 20 mg/kg dose). This review summarizes the current knowledge on oxantel pamoate and its use against T. trichiura infections in humans. Oxantel pamoate acts locally in the human gastrointestinal tract and binds to the parasite's nicotinic acetylcholine receptor (nAChR), leading to a spastic paralysis of the worm and subsequent expulsion. The drug is metabolically stable, shows low permeability and low systemic bioavailability after oral use. Oxantel pamoate was found to be safe in humans, with only a few mild adverse events reported. Several clinical trials have investigated the efficacy of this drug against T. trichiura\u00a0and suggest that oxantel pamoate is more efficacious against T. trichiura than the currently recommended drugs, which makes it a strong asset to the depleted drug armamentarium and could help delay or even prevent the development of resistance to existing drugs. We highlight existing data to support the use of oxantel pamoate against T. trichiura infections.", "keywords": ["Hookworm Infections", "03 medical and health sciences", "Trichuris", "0302 clinical medicine", "Dose-Response Relationship", " Drug", "Antinematodal Agents", "Pyrantel Pamoate", "Animals", "Humans", "Drug Interactions", "Review Article", "3. Good health"]}, "links": [{"href": "https://link.springer.com/content/pdf/10.1007/s40265-021-01505-1.pdf"}, {"href": "https://doi.org/10.1007/s40265-021-01505-1"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Drugs", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1007/s40265-021-01505-1", "name": "item", "description": "10.1007/s40265-021-01505-1", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1007/s40265-021-01505-1"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-04-30T00:00:00Z"}}, {"id": "10.1016/j.heliyon.2024.e41151", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:16:21Z", "type": "Journal Article", "created": "2024-12-14", "title": "Chlorotoxin-functionalized mesoporous silica nanoparticles for pH-responsive paclitaxel delivery to Glioblastoma multiforme", "description": "Glioblastoma multiforme (GBM) is a highly aggressive brain cancer associated with poor survival rates. We developed novel mesoporous silica nanoparticles (MSNs)-based nanocarriers for pH-responsive delivery of a therapeutic drug Paclitaxel (PTX) to GBM tumor cells. The pores of MSNs are loaded with PTX, which is retained by \u03b2-cyclodextrin (CD) moieties covalently linked to the pore entrances through a hydrazone linkage, which is cleavable in weakly acidic environment. Furthermore, we utilized a host-guest interaction between the adamantane and capping CD moieties to further functionalize the surface with a potential glioma-targeting oligopeptide chlorotoxin (CHX). In vitro studies in the U87 GBM cell line show decreased uptake, but increased toxicity of CHX-modified nanoparticles compared to CHX-free nanoparticles. The obtained results are promising toward development of advanced drug nanocarriers, which may target the overexpressed receptors in cancer tissues and utilize their weakly acidic environment for triggering the drug release, potentially leading to more efficient cancer treatments.", "keywords": ["Social sciences (General)", "H1-99", "Targeted drug delivery", "Q1-390", "Science (General)", "Paclitaxel", "Mesoporous silica nanoparticles", "Cyclodextrin", "Glioblastoma multiforme", "pH-responsive", "Research Article"]}, "links": [{"href": "https://doi.org/10.1016/j.heliyon.2024.e41151"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Heliyon", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1016/j.heliyon.2024.e41151", "name": "item", "description": "10.1016/j.heliyon.2024.e41151", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1016/j.heliyon.2024.e41151"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2025-01-01T00:00:00Z"}}, {"id": "10.1021/jf040077x", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:17:05Z", "type": "Journal Article", "created": "2004-08-18", "title": "Effects Of Selenium Treatments On Potato (Solanum Tuberosum L.) Growth And Concentrations Of Soluble Sugars And Starch", "description": "The effect of selenium (Se) treatments on potato growth and Se, soluble sugar, and starch accumulation was investigated. Potato plants were cultivated in quartz sand without or with sodium selenate (0, 0.075, 0.3 mg Se kg(-1) sand). In young potato plants, Se treatment resulted in higher starch concentrations in upper leaves. The tuber yield of Se-treated potato plants was higher and composed of relatively few but large tubers. At harvest, the starch concentration in tubers did not differ significantly between treatments. The higher Se addition (0.3 mg Se kg(-1)) may have delayed the aging of stolons and roots, which was observed as high concentrations of soluble sugar and starch. Together with the earlier results showing elevated starch concentration in Se-treated lettuce, the findings of this research justify the conclusion that Se has positive effects also on potato carbohydrate accumulation and possibly on yield formation.", "keywords": ["0106 biological sciences", "2. Zero hunger", "Dose-Response Relationship", " Drug", "Carbohydrates", "Starch", "04 agricultural and veterinary sciences", "Selenic Acid", "Plant Roots", "01 natural sciences", "Plant Leaves", "Plant Tubers", "Selenium", "0401 agriculture", " forestry", " and fisheries", "Selenium Compounds", "Solanum tuberosum"], "contacts": [{"organization": "Helin\u00e4 Hartikainen, Mervi Sepp\u00e4nen, Marja Turakainen,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/10.1021/jf040077x"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Journal%20of%20Agricultural%20and%20Food%20Chemistry", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1021/jf040077x", "name": "item", "description": "10.1021/jf040077x", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1021/jf040077x"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2004-07-27T00:00:00Z"}}, {"id": "10.1056/nejmoa2212825", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:17:28Z", "type": "Journal Article", "created": "2023-05-17", "title": "Emodepside for             Trichuris trichiura             and Hookworm Infection", "description": "Current treatments for soil-transmitted helminth infections in humans have low efficacy against Trichuris trichiura. Emodepside - a drug in veterinary use and under development for the treatment of onchocerciasis in humans - is a leading therapeutic candidate for soil-transmitted helminth infection.We conducted two phase 2a, dose-ranging, randomized, controlled trials to evaluate the efficacy and safety of emodepside against T. trichiura and hookworm infections. We randomly assigned, in equal numbers, adults 18 to 45 years of age in whom T. trichiura or hookworm eggs had been detected in stool samples to receive emodepside, at a single oral dose of 5, 10, 15, 20, 25, or 30 mg; albendazole, at a single oral dose of 400 mg; or placebo. The primary outcome was the percentage of participants who were cured of T. trichiura or hookworm infection (the cure rate) with emodepside 14 to 21 days after treatment, determined with the use of the Kato-Katz thick-smear technique. Safety was assessed 3, 24, and 48 hours after the receipt of treatment or placebo.A total of 266 persons were enrolled in the T. trichiura trial and 176 in the hookworm trial. The predicted cure rate against T. trichiura in the 5-mg emodepside group (85% [95% confidence interval {CI}, 69 to 93]; 25 of 30 participants) was higher than the predicted cure rate in the placebo group (10% [95% CI, 3 to 26]; 3 of 31 participants) and the observed cure rate in the albendazole group (17% [95% CI, 6 to 35]; 5 of 30 participants). A dose-dependent relationship was shown in participants with hookworm: the observed cure rate was 32% (95% CI, 13 to 57; 6 of 19 participants) in the 5-mg emodepside group and 95% (95% CI, 74 to 99.9; 18 of 19 participants) in the 30-mg emodepside group; the observed cure rates were 14% (95% CI, 3 to 36; 3 of 21 participants) in the placebo group and 70% (95% CI, 46 to 88; 14 of 20 participants) in the albendazole group. In the emodepside groups, headache, blurred vision, and dizziness were the most commonly reported adverse events 3 and 24 hours after treatment; the incidence of events generally increased in a dose-dependent fashion. Most adverse events were mild in severity and were self-limited; there were few moderate and no serious adverse events.Emodepside showed activity against T. trichiura and hookworm infections. (Funded by the European Research Council; ClinicalTrials.gov number, NCT05017194.).", "keywords": ["Adult", "Dose-Response Relationship", " Drug", "Antinematodal Agents", "Administration", " Oral", "Middle Aged", "Albendazole", "16. Peace & justice", "3. Good health", "03 medical and health sciences", "Feces", "Hookworm Infections", "Soil", "Young Adult", "0302 clinical medicine", "Trichuris", "Depsipeptides", "Animals", "Humans", "Trichuriasis"]}, "links": [{"href": "https://doi.org/10.1056/nejmoa2212825"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/New%20England%20Journal%20of%20Medicine", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1056/nejmoa2212825", "name": "item", "description": "10.1056/nejmoa2212825", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1056/nejmoa2212825"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2023-05-18T00:00:00Z"}}, {"id": "10.1080/00039420215633", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:17:34Z", "type": "Journal Article", "created": "2003-10-02", "title": "Rumen Fermentation And Nitrogen Balance Of Lambs Fed Diets Containing Plant Extracts Rich In Tannins And Saponins, And Associated Emissions Of Nitrogen And Methane", "description": "Tannins were added to experimental diets at levels of 1 and 2 g/kg DM (hydrolysable tannins; Castanea sativa wood extract) and saponins at 2 and 30 mg/kg DM (sarsaponin; Yucca schidigera extract). These levels were far below thresholds expected to be adverse in ruminants. Effects were measured in lambs by comparison with unsupplemented control diets calculated to be either deficient (10%) or adequate in protein. The diets consisted of hay, concentrate (1:1) and extra wheat starch with increasing body weight. Ruminal pH, VFA concentration, protozoa count and apparent digestibilities of organic matter and fibre did not differ among treatments. The low tannin dose significantly decreased bacteria count compared to the high saponin dose. Saponin supplementation and the high tannin dose showed some potential to reduce ruminal ammonia concentration. This was associated with weak trends towards lower urine N excretion (only tannins) and ammonia emission from manure. Methane release was increased by the low tannin dose compared to the unsupplemented control. Diet effects on heat production were not systematic. In conclusion, the extracts rich in tannins or saponins gave only slight indications for either increased body nitrogen retention or reduced nitrogen emission. However, effects might have been larger with more pronounced dietary protein deficit.", "keywords": ["Male", "2. Zero hunger", "Rumen", "Sheep", "Dose-Response Relationship", " Drug", "Nitrogen", "Plant Extracts", "0402 animal and dairy science", "04 agricultural and veterinary sciences", "Hydrogen-Ion Concentration", "Saponins", "Fatty Acids", " Volatile", "Animal Feed", "6. Clean water", "Fermentation", "Animals", "Animal Nutritional Physiological Phenomena", "Digestion", "Dietary Proteins", "Methane", "Tannins"], "contacts": [{"organization": "Michael Kreuzer, B.J. Sliwinski, A. Machm\u00fcller, H. R. Wettstein,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/10.1080/00039420215633"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Archiv%20f%C3%BCr%20Tierernaehrung", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1080/00039420215633", "name": "item", "description": "10.1080/00039420215633", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1080/00039420215633"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2002-12-01T00:00:00Z"}}, {"id": "10.1111/1541-4337.12727", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:17:56Z", "type": "Journal Article", "created": "2021-03-05", "title": "Antimicrobial nanoparticles and biodegradable polymer composites for active food packaging applications", "description": "Abstract<p>The food industry faces numerous challenges to assure provision of tasty and convenient food that possesses extended shelf life and shows long\uffe2\uff80\uff90term high\uffe2\uff80\uff90quality preservation. Research and development of antimicrobial materials for food applications have provided active antibacterial packaging technologies that are able to meet these challenges. Furthermore, consumers expect and demand sustainable packaging materials that would reduce environmental problems associated with plastic waste. In this review, we discuss antimicrobial composite materials for active food packaging applications that combine highly efficient antibacterial nanoparticles (i.e., metal, metal oxide, mesoporous silica and graphene\uffe2\uff80\uff90based nanomaterials) with biodegradable and environmentally friendly green polymers (i.e., gelatin, alginate, cellulose, and chitosan) obtained from plants, bacteria, and animals. In addition, innovative syntheses and processing techniques used to obtain active and safe packaging are showcased. Implementation of such green active packaging can significantly reduce the risk of foodborne pathogen outbreaks, improve food safety and quality, and minimize product losses, while reducing waste and maintaining sustainability.</p", "keywords": ["0301 basic medicine", "Polymers", "PFAS", "polyvinil alcohol", "EFSA", "MRSA", "02 engineering and technology", "multiwalled carbon nanotubes NP", "European Food Safety Agency", "perfluoroalkyl substances PGA", "food industry", " food safety", " agriculture", "cinnamon essential oil CNT", "reduced graphene oxide ROS", "biodegradable natural polymers", "Anti-Infective Agents", "polybutylene succinate", "biodegradable natural polymers CEO", "ultraviolet", "poly(glycolic acid) PHB", "generally recognized as safe MSN", "methicillin-resistant Staphylococcus aureus MWCNTs", "PBS", "perfluoroalkyl substances", "CEO", "reactive oxygen species", "2. Zero hunger", "generally recognized as safe", "PHBV", "cinnamon essential oil", "PGA", "Food and Drug Administration", "poly(3-hydroxybutyrate-co-3-hydroxyvalerate)", "Food Packaging", "PLGA", "600", "ROS", "European Food Safety Agency FDA", "Anti-Bacterial Agents", "mesoporous silica nanoparticles MRSA", "[SDV] Life Sciences [q-bio]", "food safety", "GO", "PCL", "nanoparticles PBS", "graphene oxide", "PLA", "shelf life", "poly(lactic acid)", "Food and Drug Administration GO", "0210 nano-technology", "FDA", "poly(\u03b5-caprolactone) PFAS", "nanofillers", "polybutylene succinate PCL", "CNT", "PHB", "graphene oxide GRAS", "multiwalled carbon nanotubes", "methicillin-resistant Staphylococcus aureus", "poly(hydroxybutyrate)", "reduced graphene oxide", "NP", "12. Responsible consumption", "03 medical and health sciences", "poly(hydroxybutyrate) PHBV", "rGO", "GRAS", "nanocomposites", "Animals", "poly(lactide-co-glycolide)", "carbon nanotube", "MSN", "MWCNTs", "mesoporous silica nanoparticles", "foodborne pathogens", "poly(3-hydroxybutyrate-co-3-hydroxyvalerate) PLA", "carbon nanotube EFSA", "664", "polyvinil alcohol rGO", "UV", "poly(lactic acid) PLGA", "reactive oxygen species UV", "food industry", "  food safety", " agriculture", "poly(glycolic acid)", "shelf life BNP", "13. Climate action", "PVA", "Nanoparticles", "nanoparticles", "poly(lactide-co-glycolide) PVA", "poly(\u03b5-caprolactone)"]}, "links": [{"href": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/1541-4337.12727"}, {"href": "https://doi.org/10.1111/1541-4337.12727"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Comprehensive%20Reviews%20in%20Food%20Science%20and%20Food%20Safety", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.1111/1541-4337.12727", "name": "item", "description": "10.1111/1541-4337.12727", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.1111/1541-4337.12727"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-03-04T00:00:00Z"}}, {"id": "10.2527/1996.7451144x", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:19:24Z", "type": "Journal Article", "created": "2016-08-09", "description": "The effects of alfalfa saponins on ruminal pH and VFA concentrations, protozoal numbers, forestomach motility, and digesta flow from the rumen were examined in this experiment. In a preliminary study, either 800 or 1600 mg/kg of saponins per kg BW were administered intraruminally in a single dose to one of two 60-kg wethers. Ruminal contractions were suppressed within 15 min. The study was terminated when one wether didn't recover. Saponins were then administered intraruminally in two equal doses daily into four ruminally and duodenally cannulated wethers (60 +/- 1 kg) in amounts equivalent to 0, 200, 400, and 800 mg/kg BW daily in a 4 x 4 Latin Square arrangement. Saponins increased VFA concentrations (P = .001) and lowered ruminal pH (P = .001) after 2 d of administration. On d 2 and d 14, saponins decreased (P < .01) protozoal populations. On d 11, pressure changes during ruminal contractions increased by 79% during resting (P = .06), 202% during feeding (P = .05), and 53% during an 8-h period (P = .08) as the level of saponins increased from 0 to 800 mg/kg BW. Administered saponins increased duodenal flows of OM and total N by 19 and 26%, respectively (P = .04 and .01). Apparent total tract N digestibility was reduced (P = .02) by 5% at the highest saponin dosage. We conclude that alfalfa may contain enough saponins to adversely impact ruminoreticular motility. Saponins also caused decreased ruminal protozoal populations, increased flow of total duodenal N, and reduced ruminal and total tract apparent digestibilities.", "keywords": ["Male", "2. Zero hunger", "Rumen", "Sheep", "Dose-Response Relationship", " Drug", "0402 animal and dairy science", "04 agricultural and veterinary sciences", "Carbon Dioxide", "Saponins", "Fatty Acids", " Volatile", "Oxygen Consumption", "Intestine", " Small", "Animals", "Digestion", "Gastrointestinal Motility", "Methane", "Medicago sativa"], "contacts": [{"organization": "P T Klita, T W Fenton, G. W. Mathison, R. T. Hardin,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/10.2527/1996.7451144x"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Journal%20of%20Animal%20Science", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.2527/1996.7451144x", "name": "item", "description": "10.2527/1996.7451144x", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.2527/1996.7451144x"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "1996-01-01T00:00:00Z"}}, {"id": "10.2527/2004.8261839x", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:19:24Z", "type": "Journal Article", "created": "2016-08-09", "description": "The effects of alpha-cyclodextrin-horseradish oil complex (CD-HR) on methane production and ruminal fermentation were studied in vitro and in steers. In the in vitro study, diluted ruminal fluid (30 mL) was incubated anaerobically at 38 degrees C for 6 h with or without CD-HR, using cornstarch as substrate. The CD-HR was added at various concentrations (0, 0.17, 0.85 and 1.7 g/L). Treatment affected neither the pH of the medium nor the number of protozoa. Total VFA increased in a linear manner (P = 0.02), and NH3-N decreased quadratically (P = 0.04) as the concentration of CD-HR increased from 0.17 g/L to 1.7 g/L. Molar proportions of acetate decreased in a linear manner (P = 0.03), and propionate increased linearly (P = 0.008) with increasing concentrations of CD-HR. Production of methane was inhibited up to 90%, whereas accumulation of dihydrogen was increased 36-fold by 1.7 g/L of CD-HR supplementation relative to controls. The effect of CD-HR on methane production, ruminal fermentation and microbes, and digestibility was further investigated in vivo using four Holstein steers in a crossover design. The CD-HR supplement was mixed into the concentrate portion of a (1.5:1) Sudangrass hay plus concentrate mixture that was fed twice daily to the steers. Ruminal samples were collected 0, 2, and 5 h after the morning feeding. No effects of CD-HR supplementation on ruminal pH (P = 0.63) or protozoal numbers (P = 0.44) were observed. Molar proportion of acetate was decreased (P = 0.04) and propionate was increased (P = 0.005) by CD-HR treatment. Molar proportion of butyrate was increased (P = 0.05) in CD-HR-supplemented steers. Ruminal NH3-N was decreased (P = 0.05) by treatment. Blood plasma glucose concentration was increased (P = 0.02) and urea-N was decreased (P = 0.04) with CD-HR supplementation. Daily DMI was decreased (P = 0.04), and apparent digestibility of DM (P = 0.13), NDF (P = 0.14), and CP tended (P = 0.14) to be increased by treatment. Methane production was decreased (P = 0.03) by 19%, and the number of methanogens was also decreased (P = 0.03). Although N retention (P = 0.11), total viable bacteria (P = 0.15), and sulfate-reducing bacteria (P = 0.17) were not significantly altered by treatment, tendencies for increases were noted with CD-HR supplementation. The number of cellulolytic (P = 0.38) and acetogenic bacteria (P = 0.32) remained unchanged by treatment. These results indicate that CD-HR supplementation can be used to decrease methane production in steers.", "keywords": ["Male", "Cyclodextrins", "Wasabia", "Cross-Over Studies", "Rumen", "Dose-Response Relationship", " Drug", "0402 animal and dairy science", "Eukaryota", "04 agricultural and veterinary sciences", "Hydrogen-Ion Concentration", "In Vitro Techniques", "Fatty Acids", " Volatile", "6. Clean water", "Bacteria", " Anaerobic", "Random Allocation", "Fermentation", "Animals", "Plant Oils", "Cattle", "Digestion", "Energy Intake", "Methane"], "contacts": [{"organization": "Z. A. Lila, N. Ajisaka, K. Hara, Koji Hara, Nazimuddin Mohammed, S. Kanda, K. Mikuni, H. Itabashi,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/10.2527/2004.8261839x"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Journal%20of%20Animal%20Science", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.2527/2004.8261839x", "name": "item", "description": "10.2527/2004.8261839x", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.2527/2004.8261839x"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2004-06-01T00:00:00Z"}}, {"id": "10.3390/ijms24076573", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:19:39Z", "type": "Journal Article", "created": "2023-04-03", "title": "A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation", "description": "<?xml version='1.0' encoding='UTF-8'?><article><p>The discovery and development of new drugs are extremely long and costly processes. Recent progress in artificial intelligence has made a positive impact on the drug development pipeline. Numerous challenges have been addressed with the growing exploitation of drug-related data and the advancement of deep learning technology. Several model frameworks have been proposed to enhance the performance of deep learning algorithms in molecular design. However, only a few have had an immediate impact on drug development since computational results may not be confirmed experimentally. This systematic review aims to summarize the different deep learning architectures used in the drug discovery process and are validated with further in vivo experiments. For each presented study, the proposed molecule or peptide that has been generated or identified by the deep learning model has been biologically evaluated in animal models. These state-of-the-art studies highlight that even if artificial intelligence in drug discovery is still in its infancy, it has great potential to accelerate the drug discovery cycle, reduce the required costs, and contribute to the integration of the 3R (Replacement, Reduction, Refinement) principles. Out of all the reviewed scientific articles, seven algorithms were identified: recurrent neural networks, specifically, long short-term memory (LSTM-RNNs), Autoencoders (AEs) and their Wasserstein Autoencoders (WAEs) and Variational Autoencoders (VAEs) variants; Convolutional Neural Networks (CNNs); Direct Message Passing Neural Networks (D-MPNNs); and Multitask Deep Neural Networks (MTDNNs). LSTM-RNNs were the most used architectures with molecules or peptide sequences as inputs.</p></article>", "keywords": ["Deep Learning", "Artificial Intelligence", "Drug Discovery", "Review", "Neural Networks", " Computer", "drug discovery; drug design; artificial intelligence; machine learning; deep learning; biological evaluation; animal model; in vivo", "Algorithms", "3. Good health"]}, "links": [{"href": "https://www.mdpi.com/1422-0067/24/7/6573/pdf"}, {"href": "https://doi.org/10.3390/ijms24076573"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/International%20Journal%20of%20Molecular%20Sciences", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.3390/ijms24076573", "name": "item", "description": "10.3390/ijms24076573", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.3390/ijms24076573"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2023-03-31T00:00:00Z"}}, {"id": "10.3390/pharmaceutics13040460", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:19:42Z", "type": "Journal Article", "created": "2021-03-29", "title": "pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers", "description": "<?xml version='1.0' encoding='UTF-8'?><article><p>Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic activity. However, as their high toxicity may also affect healthy tissues, efficient and selective drug delivery systems to tumour tissues are needed. Our study focuses on the construction of such drug delivery systems for the delivery of cytotoxic Ru(II) complexes upon exposure to a weakly acidic environment of tumours. As nanocarriers, mesoporous silica nanoparticles (MSN) are utilized, whose surface is functionalized with two types of ligands, (2-thienylmethyl)hydrazine hydrochloride (H1) and (5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)hydrazine (H2), which were attached to MSN through a pH-responsive hydrazone linkage. Further coordination to ruthenium(II) center yielded two types of nanomaterials MSN-H1[Ru] and MSN-H2[Ru]. Spectrophotometric measurements of the drug release kinetics at different pH (5.0, 6.0 and 7.4) confirm the enhanced release of Ru(II) complexes at lower pH values, which is further supported by inductively coupled plasma optical emission spectrometry (ICP-OES) measurements. Furthermore, the cytotoxicity effect of the released metallotherapeutics is evaluated in vitro on metastatic B16F1 melanoma cells and enhanced cancer cell-killing efficacy is demonstrated upon exposure of the nanomaterials to weakly acidic conditions. The obtained results showcase the promising capabilities of the designed MSN nanocarriers for the pH-responsive delivery of metallotherapeutics and targeted treatment of cancer.</p></article>", "keywords": ["Ruthenium-based anti-cancer drugs", "ruthenium-based anticancer drugs", "PH-responsive drug delivery", "Mesoporous silica nanoparticles", "pH-responsive drug delivery", "02 engineering and technology", "controlled drug delivery", "01 natural sciences", "Article", "cancer treatment", "ddc:", "3. Good health", "0104 chemical sciences", "RS1-441", "Pharmacy and materia medica", "Cancer treatment", "mesoporous silica nanoparticles", "0210 nano-technology", "Controlled drug delivery"]}, "links": [{"href": "http://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://doi.org/10.3390/pharmaceutics13040460"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Pharmaceutics", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.3390/pharmaceutics13040460", "name": "item", "description": "10.3390/pharmaceutics13040460", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.3390/pharmaceutics13040460"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-03-28T00:00:00Z"}}, {"id": "10.5281/zenodo.4655380", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:21:24Z", "type": "Journal Article", "created": "2021-03-29", "title": "pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers.", "description": "<p>Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic activity. However, as their high toxicity may also affect healthy tissues, efficient and selective drug delivery systems to tumour tissues are needed. Our study focuses on the construction of such drug delivery systems for the delivery of cytotoxic Ru(II) complexes upon exposure to a weakly acidic environment of tumours. As nanocarriers, mesoporous silica nanoparticles (MSN) are utilized, whose surface is functionalized with two types of ligands, (2-thienylmethyl)hydrazine hydrochloride (H1) and (5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)hydrazine (H2), which were attached to MSN through a pH-responsive hydrazone linkage. Further coordination to ruthenium(II) center yielded two types of nanomaterials MSN-H1[Ru] and MSN-H2[Ru]. Spectrophotometric measurements of the drug release kinetics at different pH (5.0, 6.0 and 7.4) confirm the enhanced release of Ru(II) complexes at lower pH values, which is further supported by inductively coupled plasma optical emission spectrometry (ICP-OES) measurements. Furthermore, the cytotoxicity effect of the released metallotherapeutics is evaluated in vitro on metastatic B16F1 melanoma cells and enhanced cancer cell-killing efficacy is demonstrated upon exposure of the nanomaterials to weakly acidic conditions. The obtained results showcase the promising capabilities of the designed MSN nanocarriers for the pH-responsive delivery of metallotherapeutics and targeted treatment of cancer.</p>", "keywords": ["Ruthenium-based anti-cancer drugs", "ruthenium-based anticancer drugs", "PH-responsive drug delivery", "Mesoporous silica nanoparticles", "pH-responsive drug delivery", "02 engineering and technology", "controlled drug delivery", "01 natural sciences", "Article", "cancer treatment", "ddc:", "3. Good health", "0104 chemical sciences", "RS1-441", "Pharmacy and materia medica", "Cancer treatment", "mesoporous silica nanoparticles", "0210 nano-technology", "Controlled drug delivery"]}, "links": [{"href": "http://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://doi.org/10.5281/zenodo.4655380"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Pharmaceutics", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "10.5281/zenodo.4655380", "name": "item", "description": "10.5281/zenodo.4655380", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/10.5281/zenodo.4655380"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-03-28T00:00:00Z"}}, {"id": "1887/73460", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:22:42Z", "type": "Journal Article", "created": "2018-01-31", "title": "Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB2) ligand designed for PET studies", "description": "The central CB2 receptor represents a promising target for the treatment of neuroinflammatory diseases as CB2 activation mediates anti-inflammatory effects. Recently, the F-18 labeled PET radiotracer [18F]7a was reported, which shows high CB2 affinity and high selectivity over the CB1 subtype but low metabolic stability due to hydrolysis of the amide group. Based on these findings twelve bioisosteres of 7a were synthesized containing a non-hydrolysable functional group instead of the amide group. The secondary amine 23a (Ki\u202f=\u202f7.9\u202fnM) and the ketone 26a (Ki\u202f=\u202f8.6\u202fnM) displayed high CB2 affinity and CB2:CB1 selectivity in in\u00a0vitro radioligand binding studies. Incubation of 7a, 23a and 26a with mouse liver microsomes and LC-quadrupole-MS analysis revealed a slightly higher metabolic stability of secondary amine 23a, but a remarkably higher stability of ketone 26a in comparison to amide 7a. Furthermore, a logD7.4 value of 5.56\u202f\u00b1\u202f0.08 was determined for ketone 26a by micro shake-flask method and LC-MS quantification.", "keywords": ["0301 basic medicine", "Amide bioisosteres", "Halogenation", "CB(2) receptor ligands", "Ligands", "Receptor", " Cannabinoid", " CB2", "Mice", "Structure-Activity Relationship", "03 medical and health sciences", "Animals", "Humans", "Identification of metabolites", "Amines", "2. Zero hunger", "0303 health sciences", "Dose-Response Relationship", " Drug", "Molecular Structure", "Fluorinated carbazole derivatives", "Ketones", "Amides", "3. Good health", "Metabolic stabilization", "PET", "Drug Design", "Positron-Emission Tomography", "Microsomes", " Liver", "Structure affinity relationships"]}, "links": [{"href": "https://doi.org/1887/73460"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/European%20Journal%20of%20Medicinal%20Chemistry", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "1887/73460", "name": "item", "description": "1887/73460", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/1887/73460"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2018-02-01T00:00:00Z"}}, {"id": "21.15107/rcub_cer_4573", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:22:56Z", "type": "Dataset", "title": "Supplementary material to: \"Ph-responsive release of ruthenium metallotherapeutics from mesoporous silica-based nanocarriers\"", "description": "Open AccessPublished version of the article: [https://cer.ihtm.bg.ac.rs/handle/123456789/4572]", "keywords": ["Ruthenium-based anti-cancer drugs", "PH-responsive drug delivery", "Cancer treatment", "Mesoporous silica nanoparticles", "Controlled drug delivery"], "contacts": [{"organization": "Mladenovi\u0107, Minja, Morgan, Ibrahim, Ili\u0107, Neboj\u0161a, Saoud, Mohamad, Pergal, Marija, Kalu\u0111erovi\u0107, Goran N., Kne\u017eevi\u0107, Nikola \u017d.,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/21.15107/rcub_cer_4573"}, {"rel": "self", "type": "application/geo+json", "title": "21.15107/rcub_cer_4573", "name": "item", "description": "21.15107/rcub_cer_4573", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/21.15107/rcub_cer_4573"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-01-01T00:00:00Z"}}, {"id": "21645685", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:22:59Z", "type": "Journal Article", "created": "2011-04-21", "title": "Development of a solvent-free method for the simultaneous identification/quantification of drugs of abuse and their metabolites in environmental water by LC\u2013MS/MS", "description": "This work details a rapid analytical method using direct sample injection for the simultaneous identification/quantification of 22 drugs of abuse, including some of their major metabolites, in environmental samples. This has been developed using a hybrid triple quadrupole-linear ion trap-mass spectrometer (QqLIT). With the increasing sensitivity of today's tandem mass spectrometers, direct injection analysis of water samples has become an attractive alternative to traditional analytical protocols, which often include a preliminary pre-concentration step. What's more, this kind of analysis is in accordance with many of the main objectives of so-called green analytical chemistry, or environmentally friendly practice. The analytical performance of the LC-MS/MS method was evaluated in three different water matrices (surface water, influent and effluent wastewater). Data acquisition was carried out in selected reaction monitoring (SRM) mode under time-scheduled conditions, monitoring two SRM transitions for simultaneous identification/quantification of all target compounds in the samples. Additionally, an experiment was performed using the information-dependent acquisition (IDA) scan to carry out the identification of those analytes for which the second transition was present at a low intensity. Finally, the two methodologies developed were applied to real samples for evaluation.", "keywords": ["Illicit Drugs", "Tandem Mass Spectrometry", "Solid Phase Extraction", "TD Environmental technology. Sanitary engineering", "Environmental Pollutants", "TP Chemical technology", "01 natural sciences", "Water Pollutants", " Chemical", "6. Clean water", "Chromatography", " Liquid", "Environmental Monitoring", "0104 chemical sciences", "0105 earth and related environmental sciences"]}, "links": [{"href": "https://doi.org/21645685"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Talanta", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "21645685", "name": "item", "description": "21645685", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/21645685"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2011-07-01T00:00:00Z"}}, {"id": "3135523176", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:23:23Z", "type": "Journal Article", "created": "2021-03-05", "title": "Antimicrobial nanoparticles and biodegradable polymer composites for active food packaging applications", "description": "Abstract<p>The food industry faces numerous challenges to assure provision of tasty and convenient food that possesses extended shelf life and shows long\uffe2\uff80\uff90term high\uffe2\uff80\uff90quality preservation. Research and development of antimicrobial materials for food applications have provided active antibacterial packaging technologies that are able to meet these challenges. Furthermore, consumers expect and demand sustainable packaging materials that would reduce environmental problems associated with plastic waste. In this review, we discuss antimicrobial composite materials for active food packaging applications that combine highly efficient antibacterial nanoparticles (i.e., metal, metal oxide, mesoporous silica and graphene\uffe2\uff80\uff90based nanomaterials) with biodegradable and environmentally friendly green polymers (i.e., gelatin, alginate, cellulose, and chitosan) obtained from plants, bacteria, and animals. In addition, innovative syntheses and processing techniques used to obtain active and safe packaging are showcased. Implementation of such green active packaging can significantly reduce the risk of foodborne pathogen outbreaks, improve food safety and quality, and minimize product losses, while reducing waste and maintaining sustainability.</p", "keywords": ["0301 basic medicine", "Polymers", "PFAS", "polyvinil alcohol", "MRSA", "EFSA", "02 engineering and technology", "multiwalled carbon nanotubes NP", "European Food Safety Agency", "perfluoroalkyl substances PGA", "food industry", " food safety", " agriculture", "cinnamon essential oil CNT", "biodegradable natural polymers", "reduced graphene oxide ROS", "Anti-Infective Agents", "polybutylene succinate", "biodegradable natural polymers CEO", "ultraviolet", "poly(glycolic acid) PHB", "methicillin-resistant Staphylococcus aureus MWCNTs", "generally recognized as safe MSN", "PBS", "perfluoroalkyl substances", "reactive oxygen species", "CEO", "2. Zero hunger", "generally recognized as safe", "PHBV", "PGA", "cinnamon essential oil", "poly(3-hydroxybutyrate-co-3-hydroxyvalerate)", "Food and Drug Administration", "Food Packaging", "PLGA", "600", "ROS", "European Food Safety Agency FDA", "Anti-Bacterial Agents", "mesoporous silica nanoparticles MRSA", "[SDV] Life Sciences [q-bio]", "food safety", "PCL", "GO", "PLA", "nanoparticles PBS", "graphene oxide", "shelf life", "poly(lactic acid)", "Food and Drug Administration GO", "0210 nano-technology", "FDA", "poly(\u03b5-caprolactone) PFAS", "nanofillers", "polybutylene succinate PCL", "CNT", "PHB", "graphene oxide GRAS", "multiwalled carbon nanotubes", "methicillin-resistant Staphylococcus aureus", "poly(hydroxybutyrate)", "reduced graphene oxide", "NP", "12. Responsible consumption", "03 medical and health sciences", "poly(hydroxybutyrate) PHBV", "rGO", "GRAS", "nanocomposites", "Animals", "poly(lactide-co-glycolide)", "MWCNTs", "MSN", "carbon nanotube", "mesoporous silica nanoparticles", "foodborne pathogens", "poly(3-hydroxybutyrate-co-3-hydroxyvalerate) PLA", "carbon nanotube EFSA", "664", "UV", "polyvinil alcohol rGO", "poly(lactic acid) PLGA", "reactive oxygen species UV", "poly(glycolic acid)", "shelf life BNP", "13. Climate action", "PVA", "Nanoparticles", "nanoparticles", "poly(lactide-co-glycolide) PVA", "poly(\u03b5-caprolactone)"]}, "links": [{"href": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/1541-4337.12727"}, {"href": "https://doi.org/3135523176"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Comprehensive%20Reviews%20in%20Food%20Science%20and%20Food%20Safety", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "3135523176", "name": "item", "description": "3135523176", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/3135523176"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-03-04T00:00:00Z"}}, {"id": "3149801252", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:23:24Z", "type": "Journal Article", "created": "2021-03-29", "title": "pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers", "description": "<?xml version='1.0' encoding='UTF-8'?><article><p>Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic activity. However, as their high toxicity may also affect healthy tissues, efficient and selective drug delivery systems to tumour tissues are needed. Our study focuses on the construction of such drug delivery systems for the delivery of cytotoxic Ru(II) complexes upon exposure to a weakly acidic environment of tumours. As nanocarriers, mesoporous silica nanoparticles (MSN) are utilized, whose surface is functionalized with two types of ligands, (2-thienylmethyl)hydrazine hydrochloride (H1) and (5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)hydrazine (H2), which were attached to MSN through a pH-responsive hydrazone linkage. Further coordination to ruthenium(II) center yielded two types of nanomaterials MSN-H1[Ru] and MSN-H2[Ru]. Spectrophotometric measurements of the drug release kinetics at different pH (5.0, 6.0 and 7.4) confirm the enhanced release of Ru(II) complexes at lower pH values, which is further supported by inductively coupled plasma optical emission spectrometry (ICP-OES) measurements. Furthermore, the cytotoxicity effect of the released metallotherapeutics is evaluated in vitro on metastatic B16F1 melanoma cells and enhanced cancer cell-killing efficacy is demonstrated upon exposure of the nanomaterials to weakly acidic conditions. The obtained results showcase the promising capabilities of the designed MSN nanocarriers for the pH-responsive delivery of metallotherapeutics and targeted treatment of cancer.</p></article>", "keywords": ["Ruthenium-based anti-cancer drugs", "ruthenium-based anticancer drugs", "PH-responsive drug delivery", "Mesoporous silica nanoparticles", "pH-responsive drug delivery", "02 engineering and technology", "controlled drug delivery", "01 natural sciences", "Article", "cancer treatment", "ddc:", "3. Good health", "0104 chemical sciences", "RS1-441", "Pharmacy and materia medica", "Cancer treatment", "mesoporous silica nanoparticles", "0210 nano-technology", "Controlled drug delivery"]}, "links": [{"href": "http://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://doi.org/3149801252"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Pharmaceutics", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "3149801252", "name": "item", "description": "3149801252", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/3149801252"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-03-28T00:00:00Z"}}, {"id": "33665972", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:23:32Z", "type": "Journal Article", "created": "2021-03-05", "title": "Antimicrobial nanoparticles and biodegradable polymer composites for active food packaging applications", "description": "Abstract                   <p>The food industry faces numerous challenges to assure provision of tasty and convenient food that possesses extended shelf life and shows long\uffe2\uff80\uff90term high\uffe2\uff80\uff90quality preservation. Research and development of antimicrobial materials for food applications have provided active antibacterial packaging technologies that are able to meet these challenges. Furthermore, consumers expect and demand sustainable packaging materials that would reduce environmental problems associated with plastic waste. In this review, we discuss antimicrobial composite materials for active food packaging applications that combine highly efficient antibacterial nanoparticles (i.e., metal, metal oxide, mesoporous silica and graphene\uffe2\uff80\uff90based nanomaterials) with biodegradable and environmentally friendly green polymers (i.e., gelatin, alginate, cellulose, and chitosan) obtained from plants, bacteria, and animals. In addition, innovative syntheses and processing techniques used to obtain active and safe packaging are showcased. Implementation of such green active packaging can significantly reduce the risk of foodborne pathogen outbreaks, improve food safety and quality, and minimize product losses, while reducing waste and maintaining sustainability.</p", "keywords": ["0301 basic medicine", "Polymers", "PFAS", "polyvinil alcohol", "MRSA", "EFSA", "02 engineering and technology", "multiwalled carbon nanotubes NP", "European Food Safety Agency", "perfluoroalkyl substances PGA", "cinnamon essential oil CNT", "biodegradable natural polymers", "reduced graphene oxide ROS", "Anti-Infective Agents", "polybutylene succinate", "biodegradable natural polymers CEO", "ultraviolet", "poly(glycolic acid) PHB", "methicillin-resistant Staphylococcus aureus MWCNTs", "generally recognized as safe MSN", "PBS", "perfluoroalkyl substances", "reactive oxygen species", "CEO", "2. Zero hunger", "generally recognized as safe", "PHBV", "PGA", "cinnamon essential oil", "poly(3-hydroxybutyrate-co-3-hydroxyvalerate)", "Food and Drug Administration", "Food Packaging", "PLGA", "600", "ROS", "European Food Safety Agency FDA", "Anti-Bacterial Agents", "mesoporous silica nanoparticles MRSA", "[SDV] Life Sciences [q-bio]", "food safety", "PCL", "GO", "PLA", "nanoparticles PBS", "graphene oxide", "shelf life", "poly(lactic acid)", "Food and Drug Administration GO", "0210 nano-technology", "FDA", "poly(\u03b5-caprolactone) PFAS", "nanofillers", "polybutylene succinate PCL", "CNT", "PHB", "graphene oxide GRAS", "multiwalled carbon nanotubes", "methicillin-resistant Staphylococcus aureus", "poly(hydroxybutyrate)", "reduced graphene oxide", "NP", "12. Responsible consumption", "03 medical and health sciences", "poly(hydroxybutyrate) PHBV", "rGO", "GRAS", "nanocomposites", "Animals", "poly(lactide-co-glycolide)", "MWCNTs", "MSN", "carbon nanotube", "mesoporous silica nanoparticles", "foodborne pathogens", "poly(3-hydroxybutyrate-co-3-hydroxyvalerate) PLA", "carbon nanotube EFSA", "664", "UV", "polyvinil alcohol rGO", "poly(lactic acid) PLGA", "reactive oxygen species UV", "poly(glycolic acid)", "shelf life BNP", "13. Climate action", "PVA", "Nanoparticles", "nanoparticles", "poly(lactide-co-glycolide) PVA", "poly(\u03b5-caprolactone)"]}, "links": [{"href": "https://onlinelibrary.wiley.com/doi/pdf/10.1111/1541-4337.12727"}, {"href": "https://doi.org/33665972"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Comprehensive%20Reviews%20in%20Food%20Science%20and%20Food%20Safety", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "33665972", "name": "item", "description": "33665972", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/33665972"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-03-04T00:00:00Z"}}, {"id": "37195942", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:23:35Z", "type": "Journal Article", "created": "2023-05-17", "title": "Emodepside for             Trichuris trichiura             and Hookworm Infection", "description": "Current treatments for soil-transmitted helminth infections in humans have low efficacy against Trichuris trichiura. Emodepside - a drug in veterinary use and under development for the treatment of onchocerciasis in humans - is a leading therapeutic candidate for soil-transmitted helminth infection.We conducted two phase 2a, dose-ranging, randomized, controlled trials to evaluate the efficacy and safety of emodepside against T. trichiura and hookworm infections. We randomly assigned, in equal numbers, adults 18 to 45 years of age in whom T. trichiura or hookworm eggs had been detected in stool samples to receive emodepside, at a single oral dose of 5, 10, 15, 20, 25, or 30 mg; albendazole, at a single oral dose of 400 mg; or placebo. The primary outcome was the percentage of participants who were cured of T. trichiura or hookworm infection (the cure rate) with emodepside 14 to 21 days after treatment, determined with the use of the Kato-Katz thick-smear technique. Safety was assessed 3, 24, and 48 hours after the receipt of treatment or placebo.A total of 266 persons were enrolled in the T. trichiura trial and 176 in the hookworm trial. The predicted cure rate against T. trichiura in the 5-mg emodepside group (85% [95% confidence interval {CI}, 69 to 93]; 25 of 30 participants) was higher than the predicted cure rate in the placebo group (10% [95% CI, 3 to 26]; 3 of 31 participants) and the observed cure rate in the albendazole group (17% [95% CI, 6 to 35]; 5 of 30 participants). A dose-dependent relationship was shown in participants with hookworm: the observed cure rate was 32% (95% CI, 13 to 57; 6 of 19 participants) in the 5-mg emodepside group and 95% (95% CI, 74 to 99.9; 18 of 19 participants) in the 30-mg emodepside group; the observed cure rates were 14% (95% CI, 3 to 36; 3 of 21 participants) in the placebo group and 70% (95% CI, 46 to 88; 14 of 20 participants) in the albendazole group. In the emodepside groups, headache, blurred vision, and dizziness were the most commonly reported adverse events 3 and 24 hours after treatment; the incidence of events generally increased in a dose-dependent fashion. Most adverse events were mild in severity and were self-limited; there were few moderate and no serious adverse events.Emodepside showed activity against T. trichiura and hookworm infections. (Funded by the European Research Council; ClinicalTrials.gov number, NCT05017194.).", "keywords": ["Adult", "Dose-Response Relationship", " Drug", "Antinematodal Agents", "Administration", " Oral", "Middle Aged", "Albendazole", "16. Peace & justice", "3. Good health", "03 medical and health sciences", "Feces", "Hookworm Infections", "Soil", "Young Adult", "0302 clinical medicine", "Trichuris", "Depsipeptides", "Animals", "Humans", "Trichuriasis"]}, "links": [{"href": "https://doi.org/37195942"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/New%20England%20Journal%20of%20Medicine", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "37195942", "name": "item", "description": "37195942", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/37195942"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2023-05-18T00:00:00Z"}}, {"id": "39731790", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:23:38Z", "type": "Journal Article", "created": "2024-12-19", "title": "Benzimidazole analogues active against adult Schistosoma mansoni: SAR analyses, In vivo efficacy in mice, and preliminary mechanistic studies as potential inhibitors of hemozoin formation", "description": "For over three decades, praziquantel (PZQ) has been the mainstay chemotherapy for prevention and treatment of schistosomiasis. The excessive use of PZQ, coupled with the lack of advanced drug candidates in the current anti-schistosomiasis drug development pipeline, emphasizes the genuine need for new drugs. In the current work, we investigated the antischistosomal potential of a new series of compounds derived from the privileged benzimidazole scaffold, which exhibited low micromolar IC50 potency in the range of 1.0-2.7\u00a0\u03bcM against Schistosomamansoni adult worms, in vitro. However, representative compounds showed low in vivo activity. One compound (15) reduced worm burden by 51.9\u00a0%, although the reduction was not statistically significant. Furthermore, by invoking inhibition of hemozoin formation, an immutable drug target in Schistosoma adult worms, as a likely contributing mode of action, we observed that the most potent analogues were equally potent inhibitors of \u03b2-hematin (synthetic hemozoin) formation in a cell-free assay.", "keywords": ["Hemeproteins", "Anthelmintics", "Structure-Activity Relationship", "Mice", "Schistosomicides", "Molecular Structure", "Dose-Response Relationship", " Drug", "Parasitic Sensitivity Tests", "Animals", "Benzimidazoles", "Schistosoma mansoni", "Schistosomiasis mansoni"]}, "links": [{"href": "https://doi.org/39731790"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/European%20Journal%20of%20Medicinal%20Chemistry", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "39731790", "name": "item", "description": "39731790", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/39731790"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2025-02-01T00:00:00Z"}}, {"id": "50|od______4273::2f0693462ae15a3b046078254fb93f9f", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:23:51Z", "type": "Dataset", "title": "Supplementary material to: \"Ph-responsive release of ruthenium metallotherapeutics from mesoporous silica-based nanocarriers\"", "description": "Open AccessPublished version of the article: [https://cer.ihtm.bg.ac.rs/handle/123456789/4572]", "keywords": ["Ruthenium-based anti-cancer drugs", "PH-responsive drug delivery", "Cancer treatment", "Mesoporous silica nanoparticles", "Controlled drug delivery"], "contacts": [{"organization": "Mladenovi\u0107, Minja, Morgan, Ibrahim, Ili\u0107, Neboj\u0161a, Saoud, Mohamad, Pergal, Marija, Kalu\u0111erovi\u0107, Goran N., Kne\u017eevi\u0107, Nikola \u017d.,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/50|od______4273::2f0693462ae15a3b046078254fb93f9f"}, {"rel": "self", "type": "application/geo+json", "title": "50|od______4273::2f0693462ae15a3b046078254fb93f9f", "name": "item", "description": "50|od______4273::2f0693462ae15a3b046078254fb93f9f", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/50|od______4273::2f0693462ae15a3b046078254fb93f9f"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-01-01T00:00:00Z"}}, {"id": "PMC11699378", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:24:59Z", "type": "Journal Article", "created": "2024-12-14", "title": "Chlorotoxin-functionalized mesoporous silica nanoparticles for pH-responsive paclitaxel delivery to Glioblastoma multiforme", "description": "Glioblastoma multiforme (GBM) is a highly aggressive brain cancer associated with poor survival rates. We developed novel mesoporous silica nanoparticles (MSNs)-based nanocarriers for pH-responsive delivery of a therapeutic drug Paclitaxel (PTX) to GBM tumor cells. The pores of MSNs are loaded with PTX, which is retained by \u03b2-cyclodextrin (CD) moieties covalently linked to the pore entrances through a hydrazone linkage, which is cleavable in weakly acidic environment. Furthermore, we utilized a host-guest interaction between the adamantane and capping CD moieties to further functionalize the surface with a potential glioma-targeting oligopeptide chlorotoxin (CHX). In vitro studies in the U87 GBM cell line show decreased uptake, but increased toxicity of CHX-modified nanoparticles compared to CHX-free nanoparticles. The obtained results are promising toward development of advanced drug nanocarriers, which may target the overexpressed receptors in cancer tissues and utilize their weakly acidic environment for triggering the drug release, potentially leading to more efficient cancer treatments.", "keywords": ["Social sciences (General)", "H1-99", "Targeted drug delivery", "Q1-390", "Science (General)", "Paclitaxel", "Mesoporous silica nanoparticles", "Cyclodextrin", "Glioblastoma multiforme", "pH-responsive", "Research Article"]}, "links": [{"href": "https://doi.org/PMC11699378"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Heliyon", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "PMC11699378", "name": "item", "description": "PMC11699378", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/PMC11699378"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2025-01-01T00:00:00Z"}}, {"id": "PMC8067187", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:25:02Z", "type": "Journal Article", "created": "2021-03-28", "title": "pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers", "description": "<?xml version='1.0' encoding='UTF-8'?><article><p>Ruthenium complexes are attracting interest in cancer treatment due to their potent cytotoxic activity. However, as their high toxicity may also affect healthy tissues, efficient and selective drug delivery systems to tumour tissues are needed. Our study focuses on the construction of such drug delivery systems for the delivery of cytotoxic Ru(II) complexes upon exposure to a weakly acidic environment of tumours. As nanocarriers, mesoporous silica nanoparticles (MSN) are utilized, whose surface is functionalized with two types of ligands, (2-thienylmethyl)hydrazine hydrochloride (H1) and (5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)hydrazine (H2), which were attached to MSN through a pH-responsive hydrazone linkage. Further coordination to ruthenium(II) center yielded two types of nanomaterials MSN-H1[Ru] and MSN-H2[Ru]. Spectrophotometric measurements of the drug release kinetics at different pH (5.0, 6.0 and 7.4) confirm the enhanced release of Ru(II) complexes at lower pH values, which is further supported by inductively coupled plasma optical emission spectrometry (ICP-OES) measurements. Furthermore, the cytotoxicity effect of the released metallotherapeutics is evaluated in vitro on metastatic B16F1 melanoma cells and enhanced cancer cell-killing efficacy is demonstrated upon exposure of the nanomaterials to weakly acidic conditions. The obtained results showcase the promising capabilities of the designed MSN nanocarriers for the pH-responsive delivery of metallotherapeutics and targeted treatment of cancer.</p></article>", "keywords": ["Ruthenium-based anti-cancer drugs", "ruthenium-based anticancer drugs", "PH-responsive drug delivery", "Mesoporous silica nanoparticles", "pH-responsive drug delivery", "02 engineering and technology", "controlled drug delivery", "01 natural sciences", "Article", "cancer treatment", "ddc:", "0104 chemical sciences", "3. Good health", "RS1-441", "Pharmacy and materia medica", "Cancer treatment", "mesoporous silica nanoparticles", "0210 nano-technology", "Controlled drug delivery"]}, "links": [{"href": "http://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://www.mdpi.com/1999-4923/13/4/460/pdf"}, {"href": "https://doi.org/PMC8067187"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Pharmaceutics", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "PMC8067187", "name": "item", "description": "PMC8067187", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/PMC8067187"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2021-03-28T00:00:00Z"}}, {"id": "deng,2004", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:26:23Z", "type": "Journal Article", "created": "2004-04-20", "description": "Eight patients had cardiac manifestations that were life-threatening in five while taking psychotropic drugs, either phenothiazines or tricyclic antidepressants. Although most patients were receiving several drugs, Mellaril (thioridazine) appeared to be responsible for five cases of ventricular tachycardia, one of which was fatal in a 35 year old woman. Supraventricular tachycardia developed in one patient receiving Thorazine (chlorpromazine). Aventyl (nortriptyline) and Elavil (amitriptyline) each produced left bundle branch block in a 73 year old woman. Electrocardiographic T and U wave abnormalities were present in most patients. The ventricular arrhythmias responded to intravenous administration of lidocaine and to direct current electric shock; ventricular pacing was required in some instances and intravenous administration of propranolol combined with ventricular pacing in one. The tachyarrhythmias generally subsided within 48 hours after administration of the drugs was stopped. Five of the eight patients were 50 years of age or younger; only one clearly had antecedent heart disease. Major cardiac arrhythmias are a potential hazard in patients without heart disease who are receiving customary therapeutic doses of psychotropic drugs. A prospective clinical trial is suggested to quantify the risk of cardiac complications to patients receiving phenothiazines or tricyclic antidepressant drugs.", "keywords": ["Adult", "Heart Failure", "Male", "Psychotropic Drugs", "Chlorpromazine", "Digitalis Glycosides", "Lidocaine", "Arrhythmias", " Cardiac", "Antidepressive Agents", " Tricyclic", "Middle Aged", "Adrenergic Agonists", "Cardiovascular System", "3. Good health", "Electrocardiography", "03 medical and health sciences", "0302 clinical medicine", "Phenothiazines", "Humans", "Female", "Mesoridazine", "Hypotension", "Diuretics", "Aged"], "contacts": [{"organization": "Irwin B. Hanenson, David McCall, Noble O. Fowler, John C. Holmes, Te Chuan Chou,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/deng,2004"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/The%20American%20Journal%20of%20Cardiology", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "deng,2004", "name": "item", "description": "deng,2004", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/deng,2004"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "1976-02-01T00:00:00Z"}}, {"id": "kahle,2004", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:28:28Z", "type": "Journal Article", "created": "2004-04-20", "description": "Eight patients had cardiac manifestations that were life-threatening in five while taking psychotropic drugs, either phenothiazines or tricyclic antidepressants. Although most patients were receiving several drugs, Mellaril (thioridazine) appeared to be responsible for five cases of ventricular tachycardia, one of which was fatal in a 35 year old woman. Supraventricular tachycardia developed in one patient receiving Thorazine (chlorpromazine). Aventyl (nortriptyline) and Elavil (amitriptyline) each produced left bundle branch block in a 73 year old woman. Electrocardiographic T and U wave abnormalities were present in most patients. The ventricular arrhythmias responded to intravenous administration of lidocaine and to direct current electric shock; ventricular pacing was required in some instances and intravenous administration of propranolol combined with ventricular pacing in one. The tachyarrhythmias generally subsided within 48 hours after administration of the drugs was stopped. Five of the eight patients were 50 years of age or younger; only one clearly had antecedent heart disease. Major cardiac arrhythmias are a potential hazard in patients without heart disease who are receiving customary therapeutic doses of psychotropic drugs. A prospective clinical trial is suggested to quantify the risk of cardiac complications to patients receiving phenothiazines or tricyclic antidepressant drugs.", "keywords": ["Adult", "Heart Failure", "Male", "Psychotropic Drugs", "Chlorpromazine", "Digitalis Glycosides", "Lidocaine", "Arrhythmias", " Cardiac", "Antidepressive Agents", " Tricyclic", "Middle Aged", "Adrenergic Agonists", "Cardiovascular System", "3. Good health", "Electrocardiography", "03 medical and health sciences", "0302 clinical medicine", "Phenothiazines", "Humans", "Female", "Mesoridazine", "Hypotension", "Diuretics", "Aged"], "contacts": [{"organization": "Irwin B. Hanenson, David McCall, Noble O. Fowler, John C. Holmes, Te Chuan Chou,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/kahle,2004"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/The%20American%20Journal%20of%20Cardiology", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "kahle,2004", "name": "item", "description": "kahle,2004", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/kahle,2004"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "1976-02-01T00:00:00Z"}}, {"id": "kaho,2004", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:28:28Z", "type": "Journal Article", "created": "2004-04-20", "description": "Eight patients had cardiac manifestations that were life-threatening in five while taking psychotropic drugs, either phenothiazines or tricyclic antidepressants. Although most patients were receiving several drugs, Mellaril (thioridazine) appeared to be responsible for five cases of ventricular tachycardia, one of which was fatal in a 35 year old woman. Supraventricular tachycardia developed in one patient receiving Thorazine (chlorpromazine). Aventyl (nortriptyline) and Elavil (amitriptyline) each produced left bundle branch block in a 73 year old woman. Electrocardiographic T and U wave abnormalities were present in most patients. The ventricular arrhythmias responded to intravenous administration of lidocaine and to direct current electric shock; ventricular pacing was required in some instances and intravenous administration of propranolol combined with ventricular pacing in one. The tachyarrhythmias generally subsided within 48 hours after administration of the drugs was stopped. Five of the eight patients were 50 years of age or younger; only one clearly had antecedent heart disease. Major cardiac arrhythmias are a potential hazard in patients without heart disease who are receiving customary therapeutic doses of psychotropic drugs. A prospective clinical trial is suggested to quantify the risk of cardiac complications to patients receiving phenothiazines or tricyclic antidepressant drugs.", "keywords": ["Adult", "Heart Failure", "Male", "Psychotropic Drugs", "Chlorpromazine", "Digitalis Glycosides", "Lidocaine", "Arrhythmias", " Cardiac", "Antidepressive Agents", " Tricyclic", "Middle Aged", "Adrenergic Agonists", "Cardiovascular System", "3. Good health", "Electrocardiography", "03 medical and health sciences", "0302 clinical medicine", "Phenothiazines", "Humans", "Female", "Mesoridazine", "Hypotension", "Diuretics", "Aged"], "contacts": [{"organization": "Irwin B. Hanenson, David McCall, Noble O. Fowler, John C. Holmes, Te Chuan Chou,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/kaho,2004"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/The%20American%20Journal%20of%20Cardiology", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "kaho,2004", "name": "item", "description": "kaho,2004", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/kaho,2004"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "1976-02-01T00:00:00Z"}}, {"id": "oai:hrcak.srce.hr:230766", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:28:34Z", "type": "Journal Article", "title": "Razgovor s Ruijem Gomesom Coelhom. \"U razmi\u0161ljanju o ba\u0161tini ne postoji neutralnost\"", "description": "Sanja Horvatin\u010di\u0107 i Vesna Vukovi\u0107 napravile su razgovor s arheologom Ruijem Gomesom Coelhom koji u svoja arheolo\u0161ka istra\u017eivanja ba\u0161tine kre\u0107e iz kriti\u010dke pozicije s obzirom na njezinu ulogu u izgradnji Zapadnog svijeta i konstituiranju suvremenih nacionalnih dr\u017eava te njezinu spregu sa strukturama mo\u0107i. Tome suprotstavlja poimanje ba\u0161tine kao procesa koji sukobljava razli\u010dite politi\u010dke pozicije. U razgovoru se dotaknuo glavnih teorija i metoda koje su pokrenule i oblikovale nove tendencije unutar polja heritologije, progovorio o poziciji i iskustvu arheologa u tom \u201cdisonantnom\u201d polju te o istra\u017eivanju koje je proveo u Brazilu na biv\u0161im planta\u017eama kave prou\u010davaju\u0107i instituciju ropstva i posebno ulogu krajolika u njegovu odr\u017eavanju kroz ono \u0161to naziva \u201csenzornim re\u017eimom\u201d ropstva. Usto, u razgovoru je tematizirano kolonijalno naslje\u0111e u javnom prostoru suvremenog Portugala, inicijative za njegovu dekolonizaciju te Coelhovo vi\u0111enje lokalnog protuhegemonijskog naslje\u0111a narodnooslobodila\u010dke borbe.", "keywords": ["Kriti\u010dka ba\u0161tina", " arheologija suvremenog doba", " povijesna arheologija", " arheologija ropstva", " arheologija Drugog svjetskog rata", " Brazil", " Dre\u017enica", " Cambedo"], "contacts": [{"organization": "Horvatin\u010di\u0107, Sanja, Vukovi\u0107, Vesna,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/oai:hrcak.srce.hr:230766"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/Etnolo%C5%A1ka%20tribina%20%3A%20Godi%C5%A1njak%20Hrvatskog%20etnolo%C5%A1kog%20dru%C5%A1tva", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "oai:hrcak.srce.hr:230766", "name": "item", "description": "oai:hrcak.srce.hr:230766", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/oai:hrcak.srce.hr:230766"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "2019-01-01T00:00:00Z"}}, {"id": "sharrowandismail,2004", "type": "Feature", "geometry": null, "properties": {"updated": "2026-10-06T16:28:53Z", "type": "Journal Article", "created": "2004-04-20", "description": "Eight patients had cardiac manifestations that were life-threatening in five while taking psychotropic drugs, either phenothiazines or tricyclic antidepressants. Although most patients were receiving several drugs, Mellaril (thioridazine) appeared to be responsible for five cases of ventricular tachycardia, one of which was fatal in a 35 year old woman. Supraventricular tachycardia developed in one patient receiving Thorazine (chlorpromazine). Aventyl (nortriptyline) and Elavil (amitriptyline) each produced left bundle branch block in a 73 year old woman. Electrocardiographic T and U wave abnormalities were present in most patients. The ventricular arrhythmias responded to intravenous administration of lidocaine and to direct current electric shock; ventricular pacing was required in some instances and intravenous administration of propranolol combined with ventricular pacing in one. The tachyarrhythmias generally subsided within 48 hours after administration of the drugs was stopped. Five of the eight patients were 50 years of age or younger; only one clearly had antecedent heart disease. Major cardiac arrhythmias are a potential hazard in patients without heart disease who are receiving customary therapeutic doses of psychotropic drugs. A prospective clinical trial is suggested to quantify the risk of cardiac complications to patients receiving phenothiazines or tricyclic antidepressant drugs.", "keywords": ["Adult", "Heart Failure", "Male", "Psychotropic Drugs", "Chlorpromazine", "Digitalis Glycosides", "Lidocaine", "Arrhythmias", " Cardiac", "Antidepressive Agents", " Tricyclic", "Middle Aged", "Adrenergic Agonists", "Cardiovascular System", "3. Good health", "Electrocardiography", "03 medical and health sciences", "0302 clinical medicine", "Phenothiazines", "Humans", "Female", "Mesoridazine", "Hypotension", "Diuretics", "Aged"], "contacts": [{"organization": "Irwin B. Hanenson, David McCall, Noble O. Fowler, John C. Holmes, Te Chuan Chou,", "roles": ["creator"]}]}, "links": [{"href": "https://doi.org/sharrowandismail,2004"}, {"rel": "related", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/The%20American%20Journal%20of%20Cardiology", "name": "related record", "description": "related record", "type": "application/json"}, {"rel": "self", "type": "application/geo+json", "title": "sharrowandismail,2004", "name": "item", "description": "sharrowandismail,2004", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items/sharrowandismail,2004"}, {"rel": "collection", "type": "application/json", "title": "Collection", "name": "collection", "description": "Collection", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main"}], "time": {"date": "1976-02-01T00:00:00Z"}}], "links": [{"rel": "self", "type": "application/geo+json", "title": "This document as GeoJSON", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=+Drug&f=json", "hreflang": "en-US"}, {"rel": "alternate", "type": "text/html", "title": "This document as HTML", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=+Drug&f=html", "hreflang": "en-US"}, {"rel": "collection", "type": "application/json", "title": "Collection URL", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main", "hreflang": "en-US"}, {"type": "application/geo+json", "rel": "first", "title": "items (first)", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=+Drug&", "hreflang": "en-US"}, {"rel": "last", "type": "application/geo+json", "title": "items (last)", "href": "https://repository.soilwise-he.eu/cat/collections/metadata:main/items?keywords=+Drug&offset=27", "hreflang": "en-US"}], "numberMatched": 27, "numberReturned": 27, "distributedFeatures": [], "timeStamp": "2026-11-22T14:04:43.058213Z"}